A phase 1 study of erlotinib and ruxolitinib in patients with EGFR-mutant lung cancers and acquired resistance to erlotinib therapy Meeting Abstract
| Authors: | Yu, H.; Perez, L. A.; Sima, C. S.; Li, B. T.; Smith-Marrone, S.; Iqbal, A.; Paik, P.; Drilon, A.; Kris, M. G.; Bromberg, J.; Riely, G. J. |
| Abstract Title: | A phase 1 study of erlotinib and ruxolitinib in patients with EGFR-mutant lung cancers and acquired resistance to erlotinib therapy |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | egfr; acquired resistance; jak |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S321 |
| Language: | English |
| ACCESSION: | WOS:000370365101183 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30011-9 |
| Notes: | Meeting Abstract: MINI16.14 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work